What is Aditxt Inc. ?
focuses on discovery and development of biopharmaceutical products.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 6.99M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.